Tower Research Capital (TRC)’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,004
| Closed | -$22K | – | 6674 |
|
|
2022
Q4 | $22K | Sell |
1,004
-15,728
| -94% | -$332K | ﹤0.01% | 3068 |
|
|
2022
Q3 | $324K | Buy |
16,732
+14,199
| +561% | +$294K | 0.01% | 1485 |
|
|
2022
Q2 | $50K | Buy |
2,533
+1,076
| +74% | +$28.4K | ﹤0.01% | 2889 |
|
|
2022
Q1 | $43K | Sell |
1,457
-910
| -38% | -$26.6K | ﹤0.01% | 2865 |
|
|
2021
Q4 | $55K | Sell |
2,367
-1,454
| -38% | -$38.7K | ﹤0.01% | 2701 |
|
|
2021
Q3 | $119K | Buy |
3,821
+2,554
| +202% | +$79K | ﹤0.01% | 2250 |
|
|
2021
Q2 | $45K | Sell |
1,267
-780
| -38% | -$25.4K | ﹤0.01% | 3116 |
|
|
2021
Q1 | $72K | Sell |
2,047
-478
| -19% | -$17.6K | ﹤0.01% | 2837 |
|
|
2020
Q4 | $94K | Sell |
2,525
-11,339
| -82% | -$412K | ﹤0.01% | 2408 |
|
|
2020
Q3 | $463K | Buy |
13,864
+11,221
| +425% | +$327K | 0.01% | 1766 |
|
|
2020
Q2 | $70K | Buy |
+2,643
| New | +$62.3K | ﹤0.01% | 2783 |
|
|
2019
Q4 | – | Sell |
-621
| Closed | -$12K | – | 4634 |
|
|
2019
Q3 | $12K | Buy |
+621
| New | +$16.1K | ﹤0.01% | 2845 |
|
|
2019
Q2 | – | Sell |
-232
| Closed | -$7K | – | 4511 |
|
|
2019
Q1 | $7K | Sell |
232
-442
| -66% | -$11.9K | ﹤0.01% | 2905 |
|
|
2018
Q4 | $16K | Buy |
674
+668
| +11,133% | +$17.7K | ﹤0.01% | 2139 |
|
|
2018
Q3 | $0 | Sell |
6
-949
| -99% | -$31K | ﹤0.01% | 4394 |
|
|
2018
Q2 | $34K | Buy |
+955
| New | +$30.9K | ﹤0.01% | 2099 |
|
|
2018
Q1 | – | Sell |
-65
| Closed | -$2K | – | 4024 |
|
|
2017
Q4 | $2K | Buy |
65
+23
| +55% | +$583 | ﹤0.01% | 3264 |
|
|
2017
Q3 | $1K | Buy |
+42
| New | +$1K | ﹤0.01% | 3694 |
|
|
2016
Q1 | – | Sell |
-25
| Closed | – | – | 5176 |
|
|
2015
Q4 | $0 | Buy |
+25
| New | +$259 | ﹤0.01% | 5225 |
|
|
2014
Q4 | – | Sell |
-51
| Closed | -$3K | – | 4883 |
|
|
2014
Q3 | $3K | Buy |
51
+48
| +1,600% | +$2.76K | ﹤0.01% | 3649 |
|
|
2014
Q2 | $0 | Buy |
+3
| New | +$209 | ﹤0.01% | 4787 |
|
|
2013
Q4 | – | Sell |
-133
| Closed | -$13K | – | 5024 |
|
|
2013
Q3 | $13K | Buy |
+133
| New | +$17.3K | ﹤0.01% | 3022 |
|
Other funds holding ALBO
Tower Research Capital (TRC)'s ALBO Position: Q1 2023 in Review
Tower Research Capital (TRC) sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,004 shares — an estimated $22K sold.
Tower Research Capital (TRC) first reported a position in ALBO in Q3 2013 and held it in 22 quarters. The position peaked at $463K in Q3 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Tower Research Capital (TRC) reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,004 Albireo Pharma Inc shares in Q1 2023, an estimated $22K.
- Tower Research Capital (TRC) first reported a position in Albireo Pharma Inc in Q3 2013 and held it in 22 quarters.
- Tower Research Capital (TRC)'s Albireo Pharma Inc position peaked at $463K in Q3 2020.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.